1. "2014"
Formats
  1. Journal Article (2603)
  2. Meeting Abstract (1417)
  3. Book Section (235)
  4. Conference Paper (23)
  5. Book Whole (16)
  6. Review (3)
Groups
  1. Department of Medicine (1584)
  2. GSK Faculty (1082)
  3. Surgery (895)
  4. Solid Tumor Oncology Division (840)
  5. Center for Hematologic Malignancies (703)
  6. Sloan Kettering Institute Faculty (672)

More Groups

People
  1. Jedd Wolchok (71)
  2. Sergio Giralt (71)
  3. Ross Levine (69)
  4. Martin Tallman (62)
  5. Michael Berger (59)
  6. Mithat Gonen (55)

More People

Years
  1. 2014 (4297)
Publications
  1. Journal of Clinical Oncology (420)
  2. Blood (228)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Cancer Research (104)
  5. Modern Pathology (89)
  6. Laboratory Investigation (82)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (446)
  3. Springer (318)
  4. Elsevier Science, Inc. (246)
  5. Nature Publishing Group (242)
  6. American Society of Hematology (230)

More Publishers

Results (4297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concurrent molecular alterations in KRAS-mutant lung adenocarcinomas and effects on overall survival
    Meeting Abstract

    Riely, G. J.; Eng, J.; Yu, H. A.; Hsu, M.; Kris, M. G.; Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Predicting response to abiraterone acetate (AA): mRNA biomarker analysis of study COU-AA-302
    Meeting Abstract

    Ricci, D. S.; Li, W. M.; Griffin, T. W.; Gormley, M.; Henitz, E.; Ryan, C. J.; de Bono, J. S.; Attard, G.; Van Den Eertwegh, A. J. M.; Schrijvers, D. L.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL)
    Meeting Abstract

    Ribas, A.; Hodi, F. S.; Kefford, R.; Hamid, O.; Daud, A.; Wolchok, J. D.; Hwu, W. J.; Gangadhar, T. C.; Patnaik, A.; Joshua, A. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1 study of LJM716 in patients with esophageal squamous cell carcinoma, bead and neck cancer, or HER2-overexpressing metastatic breast or gastric cancer
    Meeting Abstract

    Reynolds, K. L.; Juric, D.; Baselga, J.; Alsina, M.; Tabernero, J.; Bedard, P. L.; Graham, D. M.; Gonzalez-Angulo, A. M.; Garrido-Laguna, I.; Sharma, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Body mass index (BMI) as prognostic in metastatic colorectal cancer (mCRC): A pooled analysis of 21 first-line trials in the ARCAD database
    Meeting Abstract

    Renfro, L. A.; Loupakis, F.; Adams, R. A.; Seymour, M. T.; Schmoll, H. J.; Douillard, J. Y.; Hurwitz, H.; Fuchs, C. S.; Diaz-Rubio, E.; Porschen, R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Survival following stage II/III colon cancer (CC): Accent-based comparison versus matched general population (MGP)
    Meeting Abstract

    Renfro, L. A.; Grothey, A.; Kerr, D. J.; Haller, D. G.; Andre, T.; Van Cutsem, E.; Saltz, L.; Labianca, R.; Loprinzl, C. L.; Alberts, S. R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • MGMT immunohistochemistry (IHC) and exclusion of pancreatic NET (PanNET) patients from treatment with temozolomide-based therapy
    Meeting Abstract

    Reidy, D. L.; Basturk, O.; Kriplani, A.; Abou-Alfa, G. K.; Jarnagin, W. R.; Allen, P. J.; Saltz, L.; Klimstra, D. S.; Zhang, L. Y.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • ARN-509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without prior abiraterone acetate (AA) treatment
    Meeting Abstract

    Rathkopf, D. E.; Antonarakis, E. S.; Shore, N. D.; Tutrone, R. F.; Alumkal, J. J.; Ryan, C. J.; Saleh, M. N.; Hauke, R. J.; Bandekar, R.; Maneval, E. C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Targeting reciprocal feedback inhibition in the clinic: ARN509 and PI3K pathway inhibition in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Carver, B. S.; Chen, Y.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Autio, K. A.; DeNunzio, M.; Sawyers, C. L.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Blocking and randomization to improve molecular biomarker discovery
    Meeting Abstract

    Qin, L. X.; Zhou, Q.; Bogomolniy, F.; Villafania, L.; Olvera, N.; Cavatore, M.; Satagopan, J.; Begg, C. B.; Levine, D. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save